A US pharmaceutical company says it’s in talks with European authorities seeking to stockpile its antiviral drug for monkeypox amid an "unusual international outbreak" of the virus, even though they openly admit the risk is low, if any.
Related
BOOM! Caught Red Hnded Planning a Monkey Pox Event
Quebec confirms first two cases of monkeypox; 20 other suspected cases under investigation
No comments:
Post a Comment